| Identification | |
| Name: | Platinum,[(4R,5R)-2-(1-methylethyl)-1,3-dioxolane-4,5-dimethanamine-kN4,kN5][propanedioato(2-)-kO1,kO3]-,(SP-4-2)- (9CI) |
| Synonyms: | Platinum,[2-(1-methylethyl)-1,3-dioxolane-4,5-dimethanamine-kN4,kN5][propanedioato(2-)-kO1,kO3]-,[SP-4-2-[4R-(2a,4a,5b)]]-;Heptaplatin;Platinum,[2-(1-methylethyl)-1,3-dioxolane-4,5-dimethanamine-N,N'][propanedioato(2-)-O,O']-,[SP-4-2-[4R-(2a,4a,5b)]]-;SKI 2053R; |
| CAS: | 146665-77-2 |
| Molecular Formula: | C11H20N2O6Pt |
| Molecular Weight: | 471.36 |
| InChI: | InChI=1/C8H18N2O2.C3H4O4.Pt/c1-5(2)8-11-6(3-9)7(4-10)12-8;4-2(5)1-3(6)7;/h5-8H,3-4,9-10H2,1-2H3;1H2,(H,4,5)(H,6,7);/q;;+2/p-2/t6-,7-;;/m1../s1 |
| Molecular Structure: | ![(C11H20N2O6Pt) Platinum,[2-(1-methylethyl)-1,3-dioxolane-4,5-dimethanamine-kN4,kN5][propanedioato(2-)-kO1,kO3]-,[SP...](https://img.guidechem.com/casimg/146665-77-2.gif) |
| Properties | |
| Appearance: | White Crystalline Powder |
| Specification: |
Eptaplatin , its cas register number 146665-77-2. It also can be called Heptaplatin ; [SP-4-2-[4R-(2a,4a,5b)]]-[2-(1-Methylethyl)-1,3-dioxolane-4,5-dimethanamine-N,N'][propanedioato(2-)-O,O']-platinum ; [Malonato(2-)-kappa~2~O~1~,O~3~]platinum - [(4R,5R)-2-isopropyl-1,3-dioxolane-4,5-diyl]dimethanamine (1:1) ; cis-((4R,5R)-2-Isopropyl-1,3-dioxolane-4,5-bis(methylamine)-N,N')(malonato(2-)-O,O')platinum ; and cis-Malonato((4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane)platinum(II) . Its classification code are Drug / Therapeutic Agent and Reproductive Effect. |
| Usage: | A coordination compound for treatment of cervix cancer. |
| Safety Data | |
 |
|
